The Cannabist Company Celebrates the Biden Administration’s Monumental Decision to Reschedule Cannabis
16 Mai 2024 - 7:53PM
Business Wire
The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX:
CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one
of the largest and most experienced cultivators, manufacturers, and
retailers of cannabis products in the U.S., released the following
statements in response to President Biden and his administration’s
decision to move cannabis from a Schedule I Controlled Substance to
a Schedule III Controlled Substance under the federal Controlled
Substances Act.
“This is a truly momentous and historic occasion for the entire
cannabis community. Our federal government has finally formally
accepted that cannabis has medicinal value and is following the
science that we in this industry have understood and poured our
collective passion into while supporting this movement and building
our businesses. Once finalized, this change will make
state-regulated cannabis more accessible and affordable for our
customers and patients. The end of the 280E tax code for cannabis
businesses will allow us to operate our business more sustainably
and reinvest more deeply into our teams, innovation, and product
development to benefit the communities we serve,” said David Hart,
CEO, The Cannabist Company.
“We are proud to have worked closely with the Biden
Administration through every step of this 20-month-long process.
Reclassifying cannabis is an important and pragmatic step on the
path to full legalization,” said Adam Goers, SVP – Corporate
Affairs, The Cannabist Company & the Founder and Co-Chair of
the Coalition for Cannabis Scheduling Reform (CCSR). “This move
will not only eliminate the draconian taxation of cannabis
businesses under 280E, but it will open research opportunities,
protect public health and safety, and further signal that cannabis
is being normalized under federal law.”
About The Cannabist Company (f/k/a Columbia Care)
The Cannabist Company, formerly known as Columbia Care, is one
of the largest and most experienced cultivators, manufacturers and
providers of cannabis products and related services, with licenses
in 15 U.S. jurisdictions. The Company operates 123 facilities
including 92 dispensaries and 31 cultivation and manufacturing
facilities, including those under development. Columbia Care, now
The Cannabist Company, is one of the original multi-state providers
of cannabis in the U.S. and now delivers industry-leading products
and services to both the medical and adult-use markets. In 2021,
the Company launched Cannabist, its retail brand, creating a
national dispensary network that leverages proprietary technology
platforms. The company offers products spanning flower, edibles,
oils and tablets, and manufactures popular brands including Seed
& Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber.
For more information, please visit www.cannabistcompany.com.
Caution Concerning Forward Looking Statements
This press release contains certain statements that constitute
“forward-looking information” or “forward-looking statements”
within the meaning of applicable securities laws and reflect the
Company’s current expectations regarding future events.
Forward-looking statements or information contained in this release
include, but are not limited to, statements or information with
respect to taxation of the Company as well as the Company’s ability
to execute on retail, wholesale, brand and product initiatives.
These forward-looking statements or information, which although
considered reasonable by the Company, may prove to be incorrect and
are subject to known and unknown risks and uncertainties that may
cause actual results, performance or achievements of the Company to
be materially different from those expressed or implied by any
forward-looking information. In addition, securityholders should
review the risk factors discussed under “Risk Factors” in Columbia
Care’s Form 10-K for the year ended December 31, 2023, as, filed
with Canadian and U.S. securities regulatory authorities and
described from time to time in subsequent documents filed with
applicable securities regulatory authorities.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240516901782/en/
Investor Contact
Lee Ann Evans SVP, Capital Markets
investor@cannabistcompany.com
Media Contact
Lindsay Wilson SVP, Communications
media@cannabistcompany.com
Ordinary (TG:3LP)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Ordinary (TG:3LP)
Historical Stock Chart
Von Dez 2023 bis Dez 2024